BRAF and melanoma: Mutations of the oncogene B-Raf are a common occurrence in melanoma [3] and lead to hyperactivation of the RAF/MEK/ERK signaling cascade, thereby inhibiting LKB1/AMPK activity, which would normally attenuate proliferation [4].